國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915009      Online Users : 1438
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Periodical Articles [18/18]

    Community Statistics


    Item counts issued in 3 years:10(55.56%)
    Items With Fulltext:18(100.00%)

    Download counts of the item
    Download times greater than 0:18(100.00%)
    Download times greater than 100:17(94.44%)
    Total Bitstream Download Counts:3877(0.07%)

    Last Update: 2024-12-01 09:21

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-18 of 18. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DateTitleRelation
    2024-06-24 Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease European Polymer Journal. 2024 Jun 24;214:Article number 113151.
    2024-05-09 Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function Journal of Biomedical Science. 2024 May 09;31:Article number 46.
    2023-11 Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death Pharmacological Research. 2023 Nov;197:Article number 106945.
    2023-03-28 Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
    2023-02-28 How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
    2023-02-03 MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.
    2023-01-19 The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.] Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
    2022-07-21 The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
    2022-03-16 Lon upregulation contributes to cisplatin resistance by triggering NCLX-mediated mitochondrial Ca2+ release in cancer cells Cell Death and Disease. 2022 Mar 16;13(3):Article number 241.
    2022-03-02 Discovery of potential neuroprotective agents against paclitaxel-induced peripheral neuropathy Journal of Medicinal Chemistry. 2022 Mar 2;65(6):4767-4782.
    2021-12-14 A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells Journal of Food and Drug Analysis. 2021 Dec 14;29(4):638-652.
    2021-11-09 MicroRANs: Their role in metabolism, tumor microenvironment, and therapeutic implications in head and neck squamous cell carcinoma Cancers. 2021 Nov 9;13(22):Article number 5604.
    2021-08-13 Remdesivir and cyclosporine synergistically inhibit the human coronaviruses OC43 and SARS-CoV-2 Frontiers in Pharmacology. 2021 Aug 13;12:Article number 706901.
    2021-06 Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer Cancer Medicine. 2021 Jun;10(12):4075-4086.
    2021-03-11 c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation Theranostics. 2021 Mar 11;11(11):5232-5247.
    2021-03-04 Targeting lysosomal cysteine protease cathepsin S reveals immunomodulatory therapeutic strategy for oxaliplatin-induced peripheral neuropathy Theranostics. 2021 Mar 4;11(10):4672-4687.
    2021-03-01 Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors Scientific Reports. 2021 Mar 1;11:Article number 4834.
    2021-02-24 New insights into oral squamous cell carcinoma: From clinical aspects to molecular tumorigenesis International Journal of Molecular Sciences. 2021 Feb 24;22(5):Article number 2252.

    Showing items 1-18 of 18. (1 Page(s) Totally)
    1 
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback